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Abstract 
Serous tubal intraepithelial carcinoma (STIC) is 
now considered a putative precursor lesion of 
most extrauterine high-grade serous carcinomas 
(HGSC). It is frequently reported in high-risk 
women and women with advanced-stage serous 
carcinoma. This case study reports a serous 
high-grade carcinoma (HGSC) consisting of a 
bilateral STIC with a focus of stromal invasion in 
the left tube, and a peritoneal HGSC. The 
grossly normal-appearing tubes including the 
fimbriated ends were sectioned following the 
SEE-FIM protocol. In both tubes, tumor 
aggregates were exfoliated extensively to the 
tubal lumens. The neoplastic epithelia in any 
location were diffusely positive for p53 in strong 
nuclear patterns. Pelvic lymph nodes were 
negative for tumor on serial sections and keratin 
7 immunohistochemistry, and there was no 
evidence of lymphatic vessel involvement. The 
lack of any evidence of lymphovascular invasion 
and regional lymph node metastases supports 
the interpretation of intraluminal and 
transcoelomic spread, and may be taken as 
evidence of dissemination of tubal neoplastic 
cells by exfoliation in this case. The biology of 
transcoelomic spread is reviewed in this 
manuscript. 
1Department of Pathology, Landesklinikum 
Baden-Moedling, Austria 
Introduction 
Recently, attention has been drawn to 
the junction between the fimbrial 
mucosa and the tubal serosa as well as 
to the junction between the fimbrial 
mucosa and the ovarian surface 
epithelium as the location of origin of 
some forms of epithelial ovarian 
cancer.1-3 Serous tubal intraepithelial 
carcinoma (STIC) has been identified in 
the fallopian tubes of prophylactic 
salpingo-oophorectomies of BRCA 
mutation carriers with a predilection for 
the fimbriae in about 90% of cases.2,4 
STIC is now considered a putative 
precursor lesion of most extrauterine 
high-grade serous carcinomas (HGSC). 
It is frequently reported in high-risk 
women and women with advanced-
stage serous carcinoma.5,6 
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This case study reports HGSC 
associated with a bilateral STIC at the 
fimbrial ends and infundibular regions of 
the fallopian tubes, and local stromal 
invasion in the left tube, with a primary 
presentation with ascites and 
consequent peritoneal biopsy showing 
peritoneal HGSC, followed by 
Wertheim´s operation including pelvic 
lymphadenectomy. Extensively 
examined pelvic lymph nodes were 
negative for tumor, and there was no 
evidence of lymphatic vessel 
involvement. Thus, this case may 
provide evidence for a contiguous 
spread of tumor cells from a STIC by 
exfoliation and transcoelomic spread to 
the peritoneal surface. 
Case Report 
A 42 year old woman presented with 
increasing abdominal circumference 
lasting for five days. She complained of 
flank pain and hematuria. Her familial 
history was unremarkable. She was 
para 2, had a tubal ligation 15 years 
ago, was postmenopausal for four years 
and was treated for adnexitis three 
months prior. Serologically, 
inflammatory parameters were elevated. 
On physical examination, transvaginal 
ultrasound showed moderate free fluid 
in the abdominal cavity, but uterus and 
adnexa were unremarkable. The value 
of CA125 was elevated to 682.1 kU/L.  
On computed tomography, nodular 
consolidations of the omentum were 
noted. There were no signs of bulky 
lymphadenopathy. Diagnostic 
paracentesis yielded bloody fluid. On 
cytological examination, three 
dimensional papillary clusters with 
significant nuclear polymorphism, 
hyperchromasia, and nucleoli were 
noted. The nuclei were placed 
eccentrically in the cytoplasm which 
showed some vacuolization. These 
findings were interpreted as malignant 
cells consistent with a papillary serous 
adenocarcinoma, a primary lesion of the 
peritoneum or the female genital tract. A 
subsequent core biopsy of the omental 
mass revealed HGSC. On 
immunohistochemistry, the tumor was 
strongly positive for WT1 and p53, 
consistent with a tubo-ovarian or 
peritoneal primary. A diagnostic 
laparoscopy followed by subsequent 
laparotomy was performed. The 
abdominal situs revealed a greater 
omentum abnormally thickened by 
grayish white tumor masses in diffuse 
and nodular configurations, consistent 
with an omental cake, while small 
stipple-like tumor deposits were seen on 
the bladder peritoneum. Uterus, ovaries 
and fallopian tubes were grossly 
unremarkable. A frozen section from the 
omental biopsy confirmed the previously 
diagnosed HGSC. The surgical report 
noted no infiltration of the omental tumor 
into the greater curvature of the 
stomach or transverse colon, and the 
omental cake was resected completely. 
There was no tumor involvement noted 
in the liver or spleen. The preliminary 
surgical diagnosis was suspicious for a 
primary peritoneal carcinoma. Peritoneal 
lavage yielded carcinoma cells. Surgical 
therapy included hysterectomy, bilateral 
salpingo-oophorectomy, and resection 
of the omentum majus and the 
peritoneal tumor deposits as well as 
pelvic lymphadenectomy. The latter was 
done for optimal staging since the site of 
the primary tumor was uncertain prior to 
surgery, and there was no evidence of 
suspicious lymph nodes from either 
surgery or imaging. No visible tumor 
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was left at the end of the operation. The 
patient gave written consent to the use 
of her case for this study.  
 
 
Figure 1. 
Histologically, the omental tumor 
displayed a mixed architecture of solid 
nests, abortive tubuli, and papillary 
structures associated with occasional 
psammoma bodies (Figure 1). Small 
tumor nests were noted in optically clear 
spaces, consistent with micropapillary 
growth patterns. Areas of hemorrhagic 
tumor necrosis as well as an interstitial 
round cell inflammatory infiltrate were 
seen. There was high-grade nuclear 
pleomorphism, with variation in size. 
The nuclear chromatin was coarse with 
patchy nuclear clearings. Large nucleoli 
were observed frequently. There was no 
evidence of mucin as demonstrated by 
PAS-Alcian stain. 
Immunohistochemically, the tumor was 
diffusely positive for cytokeratin 7, p53 
in strong diffuse nuclear patterns, and 
p16. The tumor cells were 
immunonegative for cytokeratin 20, 
calretinin, estrogen receptor, CEA, and 
TTF1. The rate of proliferation by Ki-67 
was at 80%. Mitoses with frequently 
atypical configurations were a common 
finding, with about 40 figures in 10 high 
power fields (X400), as were apoptotic 
bodies. Small tumor deposits were 
noted at the uterine and fallopian tube 
serosa bilaterally. PAX8 immunostaining 
showed typical nuclear reactivity of the 
omental lesion as well as the STICs. 
Since morphology and immunoprofiles 
of the STICs, omental and peritoneal 
lesions were consistent with serous high 
grade neoplasia, no further 
immunostains were performed (e.g., 
SATB2 for colorectal carcinoma which is 
CD20 positive in the vast majority of 
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cases)  
 
 
Figure 2. 
 
Figure 3. 
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The normal- appearing tubes, including 
the fimbriated ends, were sectioned 
extensively following the SEE-FIM 
protocol.7 Both tubes were embedded 
completely; the fimbriated ends were 
sectioned longitudinally. Cross sections 
of the tubes were cut at approximately 3 
mm intervals along the horizontal axis, 
the fimbriated ends were amputated and 
sectioned parallel to the long axis at 2 
mm intervals. Histologically, the tubal 
mucosa was unremarkable in most of 
the slides. However, neoplastic 
proliferations were observed at the 
infundibular regions and the fimbrial 
ends of both tubes. These epithelia 
were characterized by marked nuclear 
atypia with hyperchromasia, irregular 
outlines, increased size, exhibited 
stratification and crowding, loss of 
polarity, tufting, papillary growth 
patterns, and high nuclear-to-
cytoplasmic ratios (Figures 2,3). They 
appeared comparable to the above 
described tumor masses 
morphologically as well as 
immunohistochemically by the 
antibodies described above. In 
particular, there was diffuse and strong 
nuclear p53 expression and Ki67 indices 
were high (Figure 4). 
 
 
Figure 4. 
Occasional psammoma bodies were 
noted. In the infundibulum of the left 
tube, a small neoplastic focus of about 
1mm diameter infiltrated into the tubal 
lamina propria. In both tubes, tumor 
aggregates were detached to the tubal 
lumens extensively (Figures 4,5).  
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Figure 5. 
There was no evidence of 
lymphovascular invasion, as confirmed 
by CD31 immunostaining, consistent 
with L/V0 for staging purposes. CD31 is 
a sensitive marker for vascular and 
lymphatic endothelia that is used 
routinely in our laboratory. Another 
option would be the use of D2-40, a 
specific and sensitive marker for just 
lymphatic endothelia. However, this 
antibody was not applied in this case 
since there was no evidence of 
involvement of any endothelial lined 
spaces by tumor cells. In total, 27 
regional lymph nodes were submitted 
for histology, sectioned in 2 mm 
intervals, investigated in serial sections 
including cytokeratin 7 
immunohistochemistry, and all were 
found to be free of tumor metastases, 
micrometastases, or isolated tumor 
cells. Additionally, the ovaries were 
microscopically free of tumor. A final 
diagnosis of a bilateral STIC associated 
with a unilateral focus of invasive tubal 
HGSC and peritoneal HGSC was 
rendered. The author interpreted these 
findings as consistent with a primary 
lesion in the fallopian tubes, and a stage 
of FIGO IIIC was assigned. 
The patient received six cycles of 
chemotherapy 
(Taxol/Carboplatin/Avastin) and is on 
maintenance Avastin. There is no sign 
of tumor recurrence 25 months out from 
surgery. 
Genetic testing was not performed 
secondary to financial concerns. 
Discussion 
The origin of most non uterine HGSC in 
the fallopian tubes due to germline 
BRCA 1/2 mutations is well recognized 
in the recent literature.8 Additionally, 
sporadic cases of non-uterine HGSC 
have been shown to arise in the 
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fallopian tube fimbria in the majority of 
cases, providing further evidence for the 
tubal origin of these neoplasms.8 To this 
end, the diagnostic potential of complete 
examination of the fallopian tubes to 
identify such STICs has been 
emphasized.9 
This case study does not just add 
another case of STIC to the literature. 
Rather, it attempts to consider and 
discuss a bilateral STIC with unilateral 
tube wall infiltration and associated 
peritoneal HGSC, without evidence of 
lymphovascular space involvement and 
regional lymph node metastases. Foci of 
lamina propria infiltration in STIC cases 
have been recognized previously.8 
Bilateral STICs are mentioned in 
different studies.8,10 However, bilaterality 
is observed in a minority of cases only. 
The question has been raised whether 
STIC could represent a secondary 
metastatic spread from nongynecologic 
sites. Rabban et al. reported on tumors 
metastasizing to the fallopian tube 
mucosa with a predominance of 
adenocarcinomas and most frequent 
primaries in the colon and breast, 
potentially resembling STIC.11 Rare 
metastases originated from lymphomas, 
neuroendocrine carcinomas, and 
mesotheliomas. They pointed to a 
frequent expression of p53 as a 
potential diagnostic pitfall in such 
lesions. In the present case, the 
immunohistochemical, histochemical 
and morphologic profile as described 
above is consistent with a HGSC.  
Bilateral tubal STIC with unilateral 
focally invasive HGSC associated with 
peritoneal disease also needs to be 
investigated for a mutual relationship. 
Kuhn et al. investigated TP53 mutations 
in STIC and concurrent pelvic HGSC.12 
Their findings support a clonal 
relationship of these entities, and 
demonstrate the utility of p53 
immunostaining as a surrogate for TP53 
mutation in the histological diagnosis of 
STIC. They emphasized the     
importance of appreciation of a diffuse 
strong staining that correlates with a 
missense mutation, whereas complete 
absence of staining correlates with null 
mutations. A positive staining was 
recorded by =60% of reactive nuclei. 
Important for the study at hand is the 
observation that multiple STICs were 
generally p53 positive.12  
This case was finally interpreted as 
bilateral STIC with peritoneal metastatic 
spread. This decision was made based 
on previous studies. Kuhn et al. reported 
that the vast majority of STICs showed 
shortened telomeres, one of the earliest 
molecular changes in carcinogenesis.13 
The majority of corresponding HGSC 
showed longer telomeres. The authors 
interpreted these findings as a further 
support to the proposal that STICs are 
precursors of HGSC. Bashashati et al. 
found TP53 to be the only somatic 
mutation consistently present in all 
samples of the HGSC that they 
investigated using spatial mutational 
profiling. They also noted that the 
fallopian tube lesion was ancestral 
based on phylogenetic mapping.14 
Based on TP53 sequencing, Singh et 
al.15 suggested that STIC can even 
metastasize to the contralateral adnexa 
without peritoneal involvement. 
The spread of the tubal lesion in this 
case to the peritoneal surface and 
omentum majus needs further 
consideration. Tumor cell clusters of 
different sizes were noted in the lumina 
of both tubes. They appear as a result of 
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intraluminal shedding from the epithelial 
neoplasia, with the same 
immunohistochemical features as the 
latter and the omental tumor (p53, Ki67 
indices). Bijron et al. previously reported 
that intraluminal shedding of STIC cells 
is common and a likely route of 
abdominal spread.16 STIC, intraluminal 
tumor cells, and abdominal metastases 
displayed an identical 
immunohistochemical profile and TP53 
mutation. While Bijron et al. only 
discussed STICs, the case at hand had 
a focus of invasive disease, leaving a 
possibility of lymphatic spread. 
However, the lack of any evidence of 
lymphovascular invasion and regional 
lymph node metastases supports the 
interpretation of transcoelomic spread of 
tubal neoplastic cells by exfoliation. 
Comprehensive lymph node 
examination is needed to exclude a 
lymphatic pathway of tumor spread. 
Other recent research has 
recommended surgical staging including 
lymphadenectomy in cases of STIC.17 
Nasser et al. considered lymphangiosis 
carcinomatosa and lymph node 
metastases as evidence of a STIC as 
precursor lesion in their case of 
peritoneal HGSC. Taken together, there 
is evidence for the possibility of several 
pathways for peritoneal spread in 
STIC.18 
Conclusion 
On the basis of the criteria and studies 
discussed above, this author made a 
pragmatic decision as to the primary 
site, as proposed previously.16 The site 
of the primary lesion was assigned as 
tubal rather than peritoneal in the 
presence of a bilateral STIC and a 
locally invasive carcinoma in the 
absence of signs of lymphatic invasion, 
suggesting transcoelomic dissemination 
of metastasizing tumor cells. To the best 
of the author´s knowledge, this is the 
first report applying an extensive 
protocol to all investigated lymph nodes 
with serial sections and cytokeratin 7 
immunohistochemistry to exclude 
evidence of lymphatic spread.  
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